These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 478080
1. Effects of long term sulfonylurea therapy on plasma insulin and fasting lipid levels. Podolsky S, Burney SW. Diabete Metab; 1979 Jun; 5(2):113-7. PubMed ID: 478080 [Abstract] [Full Text] [Related]
2. Effect of short- and long-term chlorpropamide therapy on oral glucose tolerance and erythrocyte insulin receptors in non-obese non-insulin dependent diabetes mellitus. el-Andere W, Lerario AC, Wajchenberg BL. Horm Metab Res; 1987 Jun; 19(6):257-63. PubMed ID: 3623414 [Abstract] [Full Text] [Related]
3. Lipid, glucose, and insulin interrelationships in normal, prediabetic, and chemical diabetic subjects. Kyner JL, Levy RI, Soeldner JS, Gleason RE, Fredrickson DS. J Lab Clin Med; 1976 Sep; 88(3):345-58. PubMed ID: 956689 [Abstract] [Full Text] [Related]
4. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy. Sönksen PH, Lowy C, Perkins JR, Lim HS. Diabetes Care; 1984 Sep; 7 Suppl 1():59-66. PubMed ID: 6376030 [Abstract] [Full Text] [Related]
5. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide. Frier BM, Ashby JP, Nairn IM, Baird JD. Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620 [Abstract] [Full Text] [Related]
6. Long-term effect of pindolol on plasma lipids, apoproteins A, blood glucose, and serum insulin levels. Lehtonen A. Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):269-72. PubMed ID: 6430812 [Abstract] [Full Text] [Related]
7. Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus. Ferrari C, Romussi M, Bertazzoni A, Testori GP, Grimaldi MG. Biomedicine; 1978 Jun; 29(4):133-6. PubMed ID: 556385 [Abstract] [Full Text] [Related]
8. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus. Ozeki N, Hara K, Yatsuka C, Nakano T, Matsumoto S, Suetsugu M, Nakamachi T, Takebayashi K, Inukai T, Haruki K, Aso Y. Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051 [Abstract] [Full Text] [Related]
9. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Al-Waili N. Eur J Med Res; 2003 Jul 31; 8(7):295-303. PubMed ID: 12911866 [Abstract] [Full Text] [Related]
10. The effect of 1-yr sibutramine treatment on glucose tolerance, insulin sensitivity and serum lipid profiles in obese subjects. Sabuncu T, Ucar E, Birden F, Yasar O. Diabetes Nutr Metab; 2004 Apr 31; 17(2):103-7. PubMed ID: 15244102 [Abstract] [Full Text] [Related]
11. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids. Fagerberg B, Berglund A, Andersson OK, Berglund G. J Hypertens; 1992 Sep 31; 10(9):1053-61. PubMed ID: 1328365 [Abstract] [Full Text] [Related]
12. Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. Ginsberg H, Kimmerling G, Olefsky JM, Reaven GM. J Clin Invest; 1975 Mar 31; 55(3):454-61. PubMed ID: 1117064 [Abstract] [Full Text] [Related]
14. Plasma insulin and glucose levels in maturity onset diabetics treated with chlorpropamide. Shenfield GM, Logan A, Shirling D, Baird J. Diabetologia; 1977 Aug 31; 13(4):367-71. PubMed ID: 913926 [Abstract] [Full Text] [Related]
15. Increased glucose disappearance rate after short-term clofibrate administration in normal subjects and in patients with chemical diabetes. Ferrari C, Testori GP, Bertazzoni A, Romussi M, Caldara R, Frezzati S. Horm Metab Res; 1978 Jan 31; 10(1):4-6. PubMed ID: 631736 [Abstract] [Full Text] [Related]
16. A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects. Moorhouse JA. Can Med Assoc J; 1967 Mar 04; 96(9):536-9. PubMed ID: 6019354 [Abstract] [Full Text] [Related]
17. The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Paisey R, Elkeles RS, Hambley J, Magill P. Diabetologia; 1978 Aug 04; 15(2):81-5. PubMed ID: 700275 [Abstract] [Full Text] [Related]
18. The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics. Tan MH, Graham CA, Bradley RF, Gleason RE, Soeldner JS. Diabetes; 1977 Jun 04; 26(6):561-70. PubMed ID: 324835 [Abstract] [Full Text] [Related]
19. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics. Schmeltz R, Wendorff HJ, Field JB. J Clin Endocrinol Metab; 1978 Apr 04; 46(4):519-27. PubMed ID: 755038 [No Abstract] [Full Text] [Related]
20. Chronic chlorpropamide therapy of noninsulin-dependent diabetes augments basal and stimulated insulin secretion by increasing islet sensitivity to glucose. Judzewitsch RG, Pfeifer MA, Best JD, Beard JC, Halter JB, Porte D. J Clin Endocrinol Metab; 1982 Aug 04; 55(2):321-8. PubMed ID: 7045153 [Abstract] [Full Text] [Related] Page: [Next] [New Search]